Home/Filings/4/0001437749-23-028701
4//SEC Filing

TATE JEFFREY 4

Accession 0001437749-23-028701

CIK 0000922247other

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 6:06 AM ET

Size

9.1 KB

Accession

0001437749-23-028701

Insider Transaction Report

Form 4
Period: 2023-10-20
TATE JEFFREY
Director
Transactions
  • Exercise of In-Money

    Common Stock

    2023-10-20$0.71/sh+29,941$21,25892,042 total
  • Purchase

    Warrant to Purchase Common Stock

    2023-10-20+32,93532,935 total
    Exercise: $0.95From: 2023-10-20Exp: 2027-10-20Common Stock (32,935 underlying)
  • Exercise of In-Money

    Warrant to Purchase Common Stock

    2023-10-20$0.13/sh29,941$3,7430 total
    Exercise: $0.71From: 2023-04-20Exp: 2030-04-20Common Stock (29,941 underlying)
Footnotes (1)
  • [F1]The Reporting Person exercised vested Warrants (the "Original Warrants") to purchase 29,941 shares of the Issuer's common stock pursuant to a Securities Purchase Agreement dated October 20, 2023 ("Closing Date"). The Reporting Person exercised his Original Warrant in full on or prior to the Closing Date in consideration of the receipt of new warrants with an exercise price equal to $0.95 per share, to purchase 110% of the shares of the Issuer's common stock covered under the Original Warrants.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother

Related Parties

1
  • filerCIK 0001499075

Filing Metadata

Form type
4
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 6:06 AM ET
Size
9.1 KB